Search Result "ribavirin."
Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 4 Year: 2020 Page: 466-484
Author(s): Branka PetkoviÄ,SrÄan KesiÄ,Vesna PeÅ¡iÄ
Ribavirin Against Viral, Neoplastic and Inflammatory Diseases: Focus on Mechanisms of Action
Ebook: Frontiers in Drug Design and Discovery
Volume: 9 Year: 2018
Author(s): Danijela Savic,Ivana Bjelobaba,Sanja Pekovic,Irena Lavrnja
Doi: 10.2174/9781681085821118090006
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2081-2092
Author(s): A. Picardi, U. Vespasiani Gentilucci, E. M. Zardi, D. DAvola, A. Amoroso, A. Afeltra
A New Look at an Old Drug: Cumulative Effects of Low Ribavirin Doses in Amphetamine-Sensitized Rats
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 31 Year: 2020 Page: 3884-3894
Author(s): Branka PetkoviÄ,SrÄan KesiÄ,Slavica RistiÄ,Željko PavkoviÄ,Jelena Podgorac,Gordana StojadinoviÄ,Vesna PeÅ¡iÄ
Validated Spectrodensitometric Method for Simultaneous Estimation of Sofosbuvir, Ribavirin and Saxagliptin in their Pure and Pharmaceutical Dosage Forms
Journal: Current Pharmaceutical Analysis
Volume: 14 Issue: 3 Year: 2018 Page: 212-218
Author(s): Salwa R. El-Shaboury,Samia M. El-Gizawy,Noha N. Atia,Mohammad Nabil Abo-Zeid
Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection
Journal: Infectious Disorders - Drug Targets
Volume: 17 Issue: 2 Year: 2017 Page: 95-100
Author(s): Ossama A. Ahmed,Hany H. Kaisar,Nehad Hawash,Hossam Samir,Sherif S. T. Shabana,Mohamed Hassan A. Fouad,Fatma Rizk,Sherief Abd-Elsalam
Ribavirin-Induced Anemia: Mechanisms, Risk Factors and Related Targets for Future Research
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2006 Page: 3351-3357
Author(s): Stefan Russmann, Ignazio Grattagliano, Piero Portincasa, Vincenzo O. Palmieri, Giuseppe Palasciano
Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice
Journal: Infectious Disorders - Drug Targets
Volume: 19 Issue: 2 Year: 2019 Page: 179-184
Author(s): Sherief Abd-Elsalam,Rehab Badawi,Sally Elnawasany,Mohamed Yousef,Loai Mansour,Nehad Hawash,Reham A. Elkhouly,Shaimaa Soliman,Amal Selim,Abdelrahman Kobtan,Asem Elfert
Neurocognitive Changes in Chronic Hepatitis C Patients Receiving CombinationTherapy of Interferon and Ribavirin: A Systematic Review
Journal: Current Drug Therapy
Volume: 17 Issue: 5 Year: 2022 Page: 349-358
Author(s): Momin Altaf Wani,Nidhi B. Agarwal,Mohd Ashif Khan
The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2093-2100
Author(s): L. Amati, R. Cozzolongo, O. G. Manghisi, R. Cuppone, N. M. Pellegrino, D. Caccavo, E. Jirillo